Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/19278731
Conclusion of this study
Zinc supplementation augments the efficacy and speed of onset of therapeutic response to imipramine treatment, particularly in patients previously nonresponsive to antidepressant pharmacotherapies. These data suggest the participation of disturbed zinc/glutamatergic transmission in the pathophysiology of drug resistance.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study